Bayer surpassed second-quarter earnings expectations and raised its guidance for the year on strong gains in stroke prevention pill Xarelto. » Read More
European equities posted strong gains by Wednesday's close, as a rally in technology stocks and a slew of positive earnings helped boost sentiment.
U.S. stock-index futures rose on Wednesday as investors cheered better-than-expected earnings from Morgan Stanley.
Monsanto said a sweetened $125-per-share offer from chemicals group Bayer is "financially inadequate and insufficient to ensure deal certainty."
Boutique banks have increased their market share of M&A over big Wall Street firms year over year.
U.S. sovereign bond yields pared gains after gunfire was heard and jets were seen flying in the Turkish capital of Ankara.
U.S. stock indexes futures traded higher Friday after better-than-expected retail sales.
BERLIN— German drug and chemicals firm Bayer increased its offer for U.S. seed company Monsanto Co. on Thursday by $3 a share to $125, saying the move followed several weeks of private talks between the pair. Bayer did not reveal the new offer's valuation of Monsanto as debt obligations will have changed since the previous offer in May, which valued the American...
Boutique banks have taken more of traditional banks’ cherished revenue driver this year than in 2015.
Politicians and regulators out to prevent monopolies kill inversion deals put a big crimp in a key Wall Street business.
European stocks rose in late trade Thursday as Bank of England Governor Mark Carney gave a dovish speech over the fallout from the U.K.'s referendum result.
During a third-quarter earnings call, Monsanto management said talks with German suitor Bayer and other parties are ongoing.
The pace of mergers and acquisitions in agribusiness shows no signs of letting up.
2016 on track for the strongest year of foreign acquisitions in the U.S.
Dennis Gartman, the founder and publisher of the Gartman Letter, told CNBC on Wednesday that Monday and Tuesday's market gains could continue for the next couple of weeks.
Dennis Gartman, founder, editor & publisher of The Gartman Letter, comments on Monsanto's decision to reject the Bayer acquisition proposal.
Europe closed sharply up on Tuesday, as sentiment was lifted by positive U.S. trade, and strong gains from banks, insurers and retailers.
Kirsty Wilson, senior analyst at Mergermarket, looks at the potential bidders for U.S. agrichemicals giant Monsanto, including potential interest from China.
Neil Dwane, global strategist at Allianz Global Investors, says many Bayer investors will view the deal negatively as they won't own Monsanto.
John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.
Scott Moeller, director of the M&A Research Centre at Cass Business School, and John Rountree, from Novasecta, discuss the Bayer-Monsanto deal.